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Abstract
Background: Improved organization of trauma care in the acute phase has reduced mortality of trauma patients.
However, there has been limited attention for the optimal organization of post-clinical rehabilitation of trauma
patients. Therefore we developed a Transmural Trauma Care Model (TTCM). This TTCM consists of four equally
important components: 1) intake and follow up consultations by a multidisciplinary team consisting of trauma
surgeon and hospital based trauma physical therapist, 2) coordination and individual goal setting for each patient
by this team, 3) primary care physical therapy by specialized physical therapists organized in a network and 4)
E-health support for transmural communication and treatment according to protocols. The aim of the current
study is to assess the cost-effectiveness of the TTCM.
Methods: Patients will be recruited from the outpatient clinic for trauma patients of the VU University Medical
Center (VUmc) if they have at least one fracture and were discharged home. A controlled-before-and-after study
design will be used to compare the TTCM with regular care. Measurements will take place after the first outpatient
clinical visit and after 3, 6 and 9 months. Prior to the implementation of the TTCM, 200 patients (50 patients per
time point) will be included in the control group. After implementation 100 patients will be included in the
intervention group and prospectively followed. Between-group comparisons will be made separately for each time
point. In addition, the recovery pattern of patients in the intervention group will be studied using longitudinal data
analysis methods. Effectiveness will be evaluated in terms of health-related quality of life (HR-QOL), pain, functional
status, patient satisfaction, and perceived recovery. Cost-effectiveness will be assessed from a societal perspective,
meaning that all costs related to the TTCM will be taken into account including intervention, health care,
absenteeism, presenteeism and unpaid productivity. Additionally, a process evaluation will be performed to explore
the extent to which the TTCM was implemented as intended, and to identify possible facilitators and barriers
associated with its implementation.
Discussion: This planned research will give insight into the feasibility of the TTCM model in clinical practice and will
give a first indication of the cost-effectiveness of the TTCM and help us to further develop post-clinical trauma care.
Trial registration: Trial registration number: NTR5474. The Netherlands National Trial Register (NTR). Registered 12
October 2015.
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Background
Trauma accounts for 9.6% of global mortality and is the
leading cause of death during the first four decades of
life [1, 2]. Since trauma patients are typically relatively
young, the amount of Disability-Adjusted Life Years
(DALYs) lost due to trauma, is larger than from any
other disease and causes an important part of worldwide
morbidity [3]. Furthermore, major trauma has shown to
be the most important cause of long-term functional
limitations in adults aged younger than 45 years [4].
The majority of trauma patients have one or more
fractures due to their trauma, sometimes in combination
with organ system injuries. Fractures of the lower ex-
tremities in particular have a major impact on functional
status and health-related quality of life (HR-QOL) [5, 6].
Moreover, the economic burden of trauma to society is
extensive due to the associated high direct as well as
indirect costs (e.g. absenteeism costs). To illustrate, the
total costs per patient with an operatively treated verte-
bral fracture is estimated to be €66.000, of which the
majority (i.e. €47.000) is due to increased absenteeism
[7]. Due to the major impact of trauma on mortality,
morbidity, and (societal) costs, there has been increased
interest in the organization of trauma care over the last
three decades. In the literature it is frequently men-
tioned that trauma care is a chain of services, consisting
of pre-hospital care, resuscitation and in-hospital care.
During the last two decades, an improved organization
of pre-hospital and in-hospital care by developing
specialized trauma centers using Advanced Trauma Life
Support (ATLS®) guidelines, has led to a 15–25%
decrease in mortality of severe trauma patients [8–11].
Since mortality has decreased significantly due to this
re-organization of trauma care, it has been suggested
that the focus of trauma care should shift to improving
quality of life and outcome, rather than on survival of
trauma patients, because further improvements in sur-
vival rates are likely to be small [8, 11]. To improve
quality of life and outcome among trauma patients,
more attention for optimizing the rehabilitation phase
is crucial. Even though numerous studies investigated
the outcome of trauma patients, none of these studies
focused on the organization and content of post-clinical
trauma care. It is recognized that serious gaps exist be-
tween patients’ transition from acute care to rehabilita-
tion and their return to society [12–14]. Therefore the
limited focus on post-clinical trauma care is remark-
able. Recently the American Trauma Society developed
a post-clinical psychological support program, including
self-management and peer support to improve the trauma
patients’ psychosocial outcomes [15]. Nonetheless, there is
limited attention for optimizing the organization of the
post-clinical physical rehabilitation of trauma patients in
primary care, which may have led to an inefficient and/or
suboptimal rehabilitation process. After being discharged
from a hospital, the majority of Dutch trauma patients re-
habilitates in the primary care setting (i.e. treatment by a
primary care physical therapist). In contrast to secondary
and tertiary care, however, guidelines and protocols, as
well as an interdisciplinary coordination, are lacking in
primary care.
Previous research in other patient groups indicates
that post-clinical care organized in networks of experi-
enced and specialized healthcare providers is likely to
result in better clinical outcomes and lower costs com-
pared to regular care models [16]. Furthermore, a recent
feasibility study among osteoarthritis patients showed
improvements in health-related quality of life, function,
and patient satisfaction when primary care was coordi-
nated by a clinical case manager (mostly a hospital based
physical therapist or nurse practitioner) who was in
close contact with the surgeon [17]. However, whether
such an organization of the post-clinical rehabilitation
process of trauma patients also leads to improved treat-
ment outcomes is currently unknown.
The aforementioned considerations led us to develop a
new Transmural Trauma Care Model (TTCM) for
trauma patients with at least one fracture, aiming to im-
prove patient outcomes by refining the organization and
quality of the post-clinical rehabilitation process. The
TTCM is a joint initiative of hospital based physical
therapists and trauma surgeons working closely together
in the development of TTCM. The TTCM consists of
four equally important components: 1) intake and follow
up consultations by a multidisciplinary team consisting
of a trauma surgeon and a highly specialized hospital
based trauma physical therapist, 2) coordination and
individual goal setting for each patient by this team, 3)
primary care physical therapy by specifically trained
trauma physical therapists organized in a network and 4)
E-health support for transmural communication (be-
tween hospital based trauma physical therapist and pri-
mary care based physical therapist) and treatment
according to protocols. To gain insight to the new care
models’ cost-effectiveness a controlled-before-and-after
study will be conducted [18]. This article describes the
study protocol.
The proposed study aims to answer the following re-
search questions:
1) Is the TTCM effective in terms of HR-QOL, pain,
functional status, patient satisfaction and perceived
recovery compared to regular care in trauma patients
with at least one fracture?
2) Is the TTCM cost-effective from a societal perspective
(including intervention costs, health care costs,
absenteeism, presenteeism and unpaid productivity)
compared to regular care?
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3) What is the recovery pattern of patients receiving
the TTCM in terms of HR-QOL, pain, functional
status, patient satisfaction and perceived recovery
during the 9 month follow-up period?
4) What are the barriers and facilitators associated with
the implementation of the TTCM?
5) What is the reach, dose delivered, dose received, and
fidelity of the TTCM?
Methods
Design
To answer the research questions, a modified controlled-
before-and-after study will be conducted at the out-
patient clinic for trauma patients of the VU University
Medical Center (VUmc), Amsterdam, the Netherlands.
The modification of the original study design -in which
both control group and intervention group are observed
prospectively- is that in our design only the intervention
group will be prospectively followed. This modification
is required due to the limited resources available. Prior
to the implementation of the TTCM, data of 200 control
patients who received care as usual will be collected dur-
ing an inclusion period of 4 months. The control group
will consist of 4 clusters of patients who either had their
first consultation at the outpatient clinic for trauma pa-
tients of the VUmc 0 (i.e. baseline), 3, 6 or 9 months ago.
Per cluster, we aim to include approximately 50 patients,
all of whom will be asked to fill out an online question-
naire once after providing informed consent. After imple-
menting the TTCM, patients who enter the outpatient
clinic for trauma patients of the VUmc and meet the
inclusion criteria will be asked to participate in the
intervention group of the study. Patients in the inter-
vention group will be prospectively followed for
9 months (n = 100) and will be asked to fill out online
questionnaires at baseline, 3, 6 and 9 months after
their first consultation at the outpatient clinic for
trauma patients. See Fig. 1 for a detailed illustration of
the study design.
Population
A total of 300 trauma patients will be included in the
study. Both operatively and non-operatively treated pa-
tients will be included, irrespective of whether or not
they were admitted to the hospital. In order to be eli-
gible for inclusion, trauma patients have to meet the fol-
lowing inclusion criteria: having at least one traumatic
fracture, being aged >18 years, and being able to fill out
online questionnaires. In both the intervention- and
control group, the duration between the patients’ actual
trauma and their first consultation at the outpatient
clinic for trauma patients can vary, depending on the
treatment that was selected at the emergency depart-
ment (i.e. admitted to hospital or sent home). Patients
will be excluded if they have red flags (i.e. traumatic
brain injury, pathological fractures, and/or cognitive
limitations), if they do not speak Dutch, if their rehabili-
tation process takes place in a tertiary care facility, and/




Control group patients will be identified from hospital
records. All eligible patients will be contacted by phone
by one of the investigators. At this point, patients receive
further information about the study, and in- and exclu-
sion criteria will be verified by the coordinating investi-
gator. Patients who are willing to participate and eligible
will then receive an email containing a link to an online
questionnaire. Clicking the link to the online question-
naire will serve as informed consent. Patients who do
not respond within 1 week will receive a reminder email
which will be resent after another week of not respond-
ing. If the patient does not reply to both emails one of
the coordinating investigators will contact the patient by
phone to inquire whether the patient is still interested
and willing to participate as indicated earlier.
Intervention group
Intervention group patients will be identified during
their first consultation at the outpatient clinic for trauma
patients. During this consultation, patients will be in-
formed about the study purpose and procedures by one
of the investigators. Also, in- and exclusion criteria will
be verified. Patients who are willing to participate and
are eligible will receive an email containing a link to an
online questionnaire. Clicking the link to the online
questionnaire will serve as informed consent. Subse-
quently, patients will be prospectively followed and will
receive additional online questionnaires at 3, 6 and
9 months follow-up. Patients who do not respond within
1 week to one of the aforementioned online question-
naires will receive a reminder email which will be resent
after another week of non-responding. If the patient
does not reply to both emails one of the coordinating in-
vestigators will contact the patient by phone to inquire




Patients in the control group received regular care (i.e.
trauma care that was provided at the VUmc prior to im-
plementation of the TTCM). During regular care, the
trauma surgeon acts as the chief consultant and per-
forms the post-clinical consultations, unaccompanied by
professionals of other disciplines. Based on personal
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judgement, the trauma surgeon decides if and when
physical therapy in primary care is needed. After referral
to a physical therapist, patients select a primary care
physical therapist themselves, usually in their residential
area. Moreover, during a patients’ treatment by a pri-
mary care physical therapist, there is typically no regular
contact between the surgeon and the primary care phys-
ical therapist.
The transmural trauma care model (TTCM)
Patients in the intervention group will receive care ac-
cording to the TTCM at the outpatient clinic for trauma
patients at the VUmc. Pre- and in-hospital trauma care
remains unchanged and is equal to that provided to the
control group. The essence of the TTCM is a regular
feedback loop, in which the hospital team guides the
primary care team by individual goal setting for each pa-
tient (see Fig. 2 for a schematic representation of the
TTCM). The TTCM consists of four main components
and will be explained below:
a) Intake and follow up consultations by a
multidisciplinary team consisting of a trauma
surgeon and a highly specialized hospital based
trauma physical therapist. The trauma surgeon
acts as the chief consultant and is responsible for
assessing the bone- and wound healing process
and additional medical procedures, such as the
prescription of medication and indicating surgery.
The hospital based physical therapist, on the
other hand, assesses physical function (e.g.
mobility, strength, walking pattern). The trauma
surgeon and hospital based physical therapist
indicate -as a team- if and when physical therapy
in primary care is needed.
b) Coordination and individual goal setting for each
patient by the multidisciplinary hospital team. This
hospital team coordinates the patients’ rehabilitation
process. The hospital based trauma physical
therapist acts as case manager and repeatedly sets
individual goals with the patient during the
rehabilitation period.
c) Primary care physical therapy by specifically trained
trauma physical therapists organized in a network.
This innovative “VUmc trauma rehabilitation
network” consists of 40 physical therapists covering
the region of Amsterdam. Patients in the
intervention group with an indication for physical
therapy treatment in primary care will be referred to
one of the specialized trauma physical therapists of
the VUmc trauma rehabilitation network. Prior to
the implementation of TTCM, all 40 network
physical therapists will follow a two-day training
course led by trauma surgeons and hospital physical
therapists. The course covers topics such as fracture
healing, fracture treatment, complications and the
most important principles of trauma rehabilitation.
In addition, written working agreements will be
discussed during the training course to assure
optimal communication and use of IT services.
d) E-health support for transmural communication
(between hospital based trauma physical therapist
and primary care based physical therapist) and
treatment according to protocols.
Fig. 1 Study design
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For the purpose of the TTCM, an existing electronic
patient record is adapted and ten rehabilitation proto-
cols have been developed for the most common
fractures (e.g. hip, tibia, ankle, proximal humerus, ver-
tebra), which will function as guidelines for the primary
care trauma physical therapists. The protocols are
linked to a secured email device through which hospital
physical therapist and the primary care physical therap-
ist will communicate repeatedly throughout the whole
rehabilitation process.
Outcome assessment
An overview of all outcome measurements is provided
in Table 1.
Baseline characteristics
At baseline, various demographic and trauma-related
characteristics will be collected for all patients in the
control- and intervention group, including age (years),
gender (male/female), level of education (low/middle/
high), medical history (none/chronic illness/musculo-
skeletal disease), type of trauma (traffic/fall/sport), injur-
ies (upper extremity fracture/lower extremity fracture/
vertebral fracture/multi trauma), treatment (operatively/
conservatively), length of stay (days), and the well vali-
dated Injury Severity Score (ISS), used to provide an
overall injury severity score for trauma patients [19].
The ISS score takes values from 0 to 75, and patients
with an ISS > 16 are defined as multi-trauma patients. In
the current study multi trauma patients are defined as
having an ISS > 16 and/or having at least fractures in
two or more extremities. Baseline characteristics will be
collected using online questionnaires as well as data de-
rived from electronic patient records.
Primary outcome measure
The primary outcome measure is general HR-QOL,
measured using the Dutch version of the EQ-5D [20].
The EQ-5D consists of five questions representing five
dimensions; mobility, self-care, usual activities, pain/
discomfort and anxiety/depression. Each question is
scored on a 3 point scale (1–3) with higher scores indi-
cating greater severity level, resulting in a 5 digit index
representing one of the 243 health status of the EQ-5D.
Using the Dutch tariff, the participants’ EQ-5D health
status will be converted into a utility score ranging
from 0 (dead) to 1 (healthy). Additionally, quality ad-
justed life years (QALYs) will be calculated using linear
interpolation between measurement points. The EQ-5D
shows good psychometric properties in trauma patients
with one or more fractures [21–23].
Secondary outcome measures
Secondary outcome measures include pain, perceived re-
covery, functional status, patient satisfaction, and disease-
specific HR-QOL.
Pain will be measured using an 11-point numeric rating
scale (NRS) ranging from 0 (no pain) to 10 (worst possible
pain) [24]. Patients will be asked to rate their average pain
over the last 7 days.
Fig. 2 Schematic representation of the TTCM
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Perceived recovery will be measured using the Global
Perceived Effect Scale. In clinical practice, measurement
of patient-rated recovery often takes the form of the
question: to what extent have you improved (or deterio-
rated) since last time? This type of rating of perceived
recovery is a “transition scale” or Global Perceived Effect
(GPE) scale, which has been advocated to increase the
relevance of information from clinical trials to clinical
practice [25]. From the patients’ perspective, the ques-
tion is intuitively easy to understand and it allows them
to rate those aspects of recovery that are most important
to them. In the current study, patients will be asked
the following question: “to what extend have you re-
covered since your trauma?” The GPE scale asks the
patient to rate, on a 7 item scale, how much their con-
dition has improved or deteriorated since their trauma.
Possible answers include 1) completely recovered, 2)
much improved, 3) slightly improved, 4) not changed,
5) slightly worsened 6) much worsened and 7) worse
than ever [26].
Functional status will be measured using the Patient
Specific Function Scale (PSFS), a patient specific out-
come measure that is intended to complement the
findings of generic- or condition-specific measures
[27]. Patients will be asked to identify three important
activities that they are having difficulty with or are un-
able to perform. Subsequently, patients are asked to
rate their current level of difficulty associated with
each activity, on an 11-point numeric rating scale ran-
ging from 0 (“unable to perform activity”) to 10 (“able
to perform activity at same level as before injury or
problem”). The PSFS is translated and validated for
the Dutch population [28].
Patient satisfaction will be scored using an 11 point
numeric rating scale ranging from 0 (very dissatisfied)
to 10 (excellent). Five patient satisfaction components
related to the TTCM will be evaluated: 1) total treat-
ment, 2) treatment at the outpatient clinic, 3) treatment
in primary care, 4) collaboration between practitioners
from the hospital team and 5) collaboration between
the hospital team and the primary care physical
therapist.
Disease-specific HR-QOL will be measured using one of
the following disease-specific function scales, appropriate
to the patients’ specific injury type (i.e. upper extremity
fractures, lower extremity- and hip fractures, vertebral
fractures and multi trauma patients):
Patients with fractures of the upper extremity will fill
out the Quick Dash score, a short version of the Dash
score (Disabilities of the Arm, Shoulder and Hand score)
[29]. The Quick Dash score consists of 11 items, meas-
uring physical function and symptoms on a five point
scale (1–5 with higher scores indicating greater diffi-
culty) in people with any or multiple musculoskeletal
disorders of the upper limb. A validated Dutch version is
available and will be used in this study [30].
Physical function in patients with hip fractures or other
lower extremity fractures will be measured using the
Lower Extremity Functional Scale (LEFS) [31]. The LEFS
is a 20-item disease-specific questionnaire developed for
Table 1 Overview of all outcome measurements
Outcome Measurement Instrument Short term Items Itemscore Interpretation
General HR-QOL EQ-5D EQ-5D 5 1–3 higher score: better health
Pain Numeric Pain Rating Scale NPRS 1 0–10 higher score: more pain
Perceived recovery Global Perceived Effect GPE 2 1–7 higher score: less recovery
Functional status Patient Specific Function Scale PSFS 3 100 mm VAS higher score: less function
Patient satisfaction Numeric Rating Scale NRS 5 0–10 higher score: more satisfaction
Disease specific HR-QOL
(upper extremity)












Groningen Activity Restriction Scale GARS 18 1–4 sumscore 18–72, higher score: more
restrictions
Healthcare utilization Retrospective Cost Questionnaires costs in Euro’s
Absenteeism PROductivity and DISease
Questionnaire
PRODISQ 1 total number of sick leave days
Presenteeism WHO Health and Work Performance
Questionnaire (NRS)
WHO-HPQ 1 0–10 higher score: better performance
at work
Unpaid productivity loss 1 hours per week unable to perform
unpaid activities
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measuring physical function in patients with musculoskel-
etal problems of the lower extremities. Each item is rated
on a five point scale (0–4 with higher scores representing
higher levels of functioning). The LEFS is frequently used
as outcome measure in patients with fractures of the
lower extremity [32]. A validated Dutch version of the
LEFS will be used in this study [33].
Patients with vertebral fractures will fill out the Roland
Morris Disability Score (RMDS) [34]. The RMDS is a
disease-specific self-reported questionnaire consisting of
24 items all of which contain two answering categories
(yes/no). The RMDS was originally developed for meas-
uring function in patients with chronic low back pain,
but is frequently used to evaluate outcome in patients
with traumatic vertebral fractures (operated as well as
conservatively treated). A validated Dutch version is
available and will be used in this study [35].
Physical functioning in multi trauma patients will be
assessed using the Groningen Activity Restriction Scale
(GARS) [36]. The GARS is an 18 item scale on daily
activities, all of which contain four response categories
ranging from 1 to 4 representing 1 (being fully inde-
pendent of other people) to four (being fully dependent
of other people). The sum score provides information
on the level of difficulty a person experiences in care
taking and household activities. Recent research indi-
cates good psychometric properties in a Dutch popula-
tion of multi trauma patients [37].
Costs
Costs will be considered from a societal perspective,
meaning that all costs related to the TTCM will be taken
into account including intervention, health care, absentee-
ism, presenteeism and unpaid productivity. Except for
intervention costs, costs will be assessed using retrospect-
ive cost questionnaires at baseline, 3, 6 and 9 months
follow-up. Recall periods of these questionnaires will vary
between treatment groups and measurement points in
order to cover the complete duration of follow-up. To
illustrate, 3-month recall periods will be used for the inter-
vention group at all measurement points, whereas re-
call periods of 3, 6 and 9 months will be used for
baseline/3-month follow-up, 6-month follow-up, and
9-month follow-up for the control group, respectively.
All costs will be converted to the same reference year
using consumer price indices. Discounting of costs
will not be necessary due to the 9-month follow-up
period.
Intervention costs will consist of all costs related to
development and implementation of the TTCM (i.e.
personnel costs, material costs, costs of the electronic
patient record, educational costs). Intervention costs
will be estimated using a bottom-up micro costing
approach in which detailed data are collected
regarding the TTCM’s units of resource use as well as
their respective unit prices [38, 39].
Health care utilization will include primary care (e.g.
consultations at the general practitioner or physical
therapist) and secondary care (e.g. consultations at the
outpatient clinic for trauma patients, hospitalization) as
well as the use of medication. Dutch standard costs will
be used to value health care costs [39]. Use of medica-
tion will be valued using the G-standard of the Dutch
Society of Pharmacy [40].
Absenteeism will be retrospectively assessed using the
“PROductivity and DISease Questionnaire” (PRODISQ)
asking patients to report their total number of sick leave
days [41]. Absenteeism will be valued using age- and
gender-specific price weights [39].
Presenteeism is defined as reduced productivity while at
work and will be assessed using the World Health
Organization Health and Work Performance Questionnaire
[42]. Presenteeism will be valued using age- and gender-
specific price weights [39].
Unpaid productivity losses will be assessed by asking
patients for how many hours per week they were unable
to perform their unpaid activities, such as domestic
work, school and voluntary work. Dutch shadow prices
will be used to value unpaid productivity [39].
Process evaluation
A process evaluation will be performed to explore the
extent to which the TTCM was implemented as intended
as well as the possible facilitators and barriers associated
with its implementation.
The extent to which the TTCM was implemented will
be explored by assessing the four process evaluation
components of Linnan and Steckler, including reach,
dose delivered, dose received, and fidelity [43]. Reach is
defined as the proportion of the intended target audi-
ence that eventually participated in the intervention
(i.e. the TTCM). Dose delivered is defined as the num-
ber of intended units of the intervention provided (e.g.
number of scheduled consultations/treatment sessions).
Dose received is the extent to which trauma patients
actively engaged in the intervention (e.g. number of
attended consultations/treatment sessions in relation to
the number that was scheduled). Fidelity is the extent
to which the intervention was delivered as planned (i.e.
the extent to which the intervention protocol was
followed by the various care providers). To explore
these four process evaluation components, data will be
collected from the intervention group participants’
electronic patient records (e.g. number of secured
emails, number of treatments in primary care, was the
treatment according the protocol?).
Barriers and facilitators are defined as factors that
hampered or enhanced the implementation of the
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TTCM, respectively [44]. For exploring the barriers and
facilitators associated with the implementation of the
TTCM, focus groups will be conducted among trauma
patients (two focus groups consisting of five patients
each), trauma surgeons (one focus group of six trauma
surgeons), hospital based physical therapists (one focus
group of five hospital based physical therapists), and pri-
mary care network physical therapists (two focus groups
consisting of five primary care network physical ther-
apists). Focus groups will be conducted at a time and
location convenient to the participants. Prior to the
focus groups, participants will be assured of confiden-
tiality and will be asked to provide informed consent.
The focus groups will be guided by two researchers,
familiar with the TTCM, but not involved as care
provider in the TTCM. During the focus groups,
three round table discussions will be held; the first
will be aimed at identifying possible facilitators, the
second will be aimed at identifying possible barriers
and the third round will be aimed at complementing
and validating the barriers and facilitators identified
in round one and two. During all round table discus-
sions, a topic list will be used as a guide, but partici-
pants are allowed to discuss other topics that they
consider to be of importance as well. All focus groups
will be audiotaped and transcribed verbatim.
Data analysis
Descriptive statistics
Descriptive statistics will be used to compare baseline
characteristics between control- and intervention group
participants and participants with complete and incom-
plete data.
Handling missing data
Missing data are assumed to be at random and will be im-
puted using Fully Conditional Specification and Predictive
Mean Matching [45]. An imputation model will be con-
structed, including variables related to the “missingness”
of data, variables that predict the outcomes, and all avail-
able midpoint and follow-up cost and effect measure
values. The number of imputed data sets will be deter-
mined based on the number of participants with complete
cost and effect measure values [46]. All of the imputed
datasets will be analysed separately as specified below.
Pooled estimates were subsequently calculated using
Rubin’s rules [46].
Clinical effectiveness
The clinical effectiveness analyses will consist of two parts.
First, the TTCMs’ effectiveness in terms of HR-QOL, pain,
perceived recovery, functional status and patient satisfac-
tion compared with usual care will be explored at 3, 6 and
9 months follow-up using regression analyses. The four
clusters of control patients (i.e. time after their first con-
sultation at the outpatient clinic for trauma patients re-
spectively 0, 3, 6 and 9 months) will be compared with the
patients in the intervention group at the corresponding
time points. Second, the recovery pattern of patients in of
the intervention group will be studied using longitudinal
data analysis in terms of HR-QOL, pain, perceived recov-
ery, functional status and patient satisfaction during the
9 month follow-up period (and while receiving the
TTCM). All of the aforementioned analyses will be cor-
rected for confounders if necessary (e.g. age, gender, level
of education). Confounding will be checked by adding the
potential confounding variable to the crude models, and
will subsequently be considered to be present if the re-
gression coefficient changes by 10% or more. All of the
clinical effectiveness analyses will be performed in SPSS,
using a level of significance of p < 0.05.
Economic evaluation
The economic evaluation will be performed from the so-
cietal perspective, meaning that all costs and conse-
quences related to the intervention will be taken into
account, irrespective of who pays or benefits. The mean
difference in total costs between the intervention and
control group will be compared to the corresponding
mean difference in effects. For this, cost and effect dif-
ferences will be estimated using seemingly unrelated re-
gression analyses in order to correct for their possible
correlation. To deal with the highly skewed nature of
cost data, 95%CIs around the differences in costs will be
estimated using the Bias Corrected and Accelerated
Bootstrap method, with 5000 replications. Incremental
Cost Effectiveness Ratios (ICERs) will be calculated by
dividing the differences in costs by those in effects. To
graphically illustrate the uncertainty surrounding the
ICERs, bootstrapped incremental cost-effect pairs will be
plotted on cost-effectiveness planes [47]. A summary
measure of the joint uncertainty of costs and effects
will be presented using cost-effectiveness acceptability
curves, indicating the probability of an intervention
being cost-effective in comparison with the control
condition for a range of willingness-to-pay values (i.e.
the maximum amount of money decision-makers are
willing to pay per unit of effect gained) [48]. To test
the robustness of the results, various sensitivity ana-
lyses will be performed [49]. All of the economic
evaluation analyses will be performed in STATA,
using a level of significance of p < 0.05.
Process evaluation
Using Nvivo, data derived from the focus groups will be
analyzed in accordance to the constant comparative ap-
proach. That is, analytic categories will be inductively
established by constantly comparing and checking items
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with the rest of the data [50]. By starting with open cod-
ing, descriptive themes and subthemes will be generated
by one researcher. The final codes will subsequently be
developed through discussion between two independent
researchers. During these discussions, similar codes will
be grouped into analytical categories and the different
properties of these categories will be explored as well as
the relationships between them (i.e. selective coding)
[51]. Using SPSS, summary statistics will be prepared to
evaluate the new care model’s reach, dose delivered, dose
received, and fidelity.
Discussion
Traumatic fractures are common and pose a substantial
economic burden to society. Nonetheless, little is
currently known about how to optimally organize the
post-clinical rehabilitation process for trauma patients
transferred from hospital to primary care. Therefore,
the TTCM for the post-clinical rehabilitation of trauma
patients was developed at the VUmc, which aims to
improve HR-QOL, functional outcome and patient
satisfaction of trauma patients, by organizing the post-
clinical rehabilitation in an innovative and more
efficient way. Within the available resources, the
aforementioned modified controlled before and after
design was regarded as the most optimal research de-
sign at this stage. The study aims to provide insight
into the new care models’ cost-effectiveness and aims
to provide clues as to how to further optimize the
TTCM so it is “ready-to-implement” in other hospitals,
which can possibly serve as a starting point for a future
pragmatic (multicenter) controlled randomized trial.
We are of the opinion that even though the applied
modified controlled before and after design might bear
on the internal validity of the current study findings
(e.g. due to selection bias), it does not negate the value
of its results. Another possible limitation of the pro-
posed study might be the difficulty to identify what
components of the TTCM will be responsible for (posi-
tive) effects. To illustrate, better clinical outcome could
be the result of better educated physical therapists in
primary care, but could also be due to the introduction
of multidisciplinary consultations at the outpatient
clinic for trauma patients. In the current study, a prag-
matic design will be applied, in which the TTCM is
evaluated as whole. Future research will therefore be
needed to provide insight into which TTCM compo-
nent is accountable for which specific effect.
Despite the shortcomings of the study we aim to pro-
vide insight in organizing the post-clinical rehabilitation
process for trauma patients in a more efficient way and
consequently contribute to better clinical outcomes and
reduced societal costs.
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